Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the study documentation.
    Difference
    0.1%
    Check dated 2026-08-31T17:23:24.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision metadata has been updated to v3.6.5, signaling a minor version update to the study record documentation.
    Difference
    0.1%
    Check dated 2026-08-10T11:42:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3. This reflects a newer page version without changing the study details or navigation.
    Difference
    0.1%
    Check dated 2026-07-27T06:30:41.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Footer credits now display the Moffitt Cancer Center branding and the full institution name, along with a new 'Helpful Links Provided by' label, and the site revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T12:47:31.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    The page now displays a revision tag of v3.6.2, replacing the previous v3.6.0, indicating a recent site update to the page.
    Difference
    0.1%
    Check dated 2026-06-28T08:42:49.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Added recruitment-status notice 'No longer looking for participants' and new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Updated the 'Intervention / Treatment' heading to 'Intervention/Treatment' and bumped the revision tag to v3.6.0 (removing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-13T17:32:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.